Research Article
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
Table 2
FTIR spectrum of fluvastatin and the ruthenium-fluvastatin complex (band position (cm-1)).
|